TS
KITE

Twin Securities’s Kite Pharma, Inc. KITE Stock Holding History

Twin Securities’s Portfolio KITE Stock Details KITE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-223,059
Closed -$40.1M – 23
2017
Q3 		$40.1M Buy
+223,059
New +$31.1M 5.42% 7

Twin Securities's KITE Position: Q4 2017 in Review

Twin Securities sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 223,059 shares — an estimated $40.1M sold.

Twin Securities first reported a position in KITE in Q3 2017 and held it in 1 quarter. The position peaked at $40.1M in Q3 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

  • Twin Securities reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
  • Twin Securities sold 223,059 Kite Pharma, Inc. shares in Q4 2017, an estimated $40.1M.
  • Twin Securities first reported a position in Kite Pharma, Inc. in Q3 2017 and held it in 1 quarter.
  • Twin Securities's Kite Pharma, Inc. position peaked at $40.1M in Q3 2017.
  • 0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on Twin Securities's 13F filing for Q4 2017, filed 14 Feb 2018.